Skip to main content
Clinical Trials/IRCT20110425006280N13
IRCT20110425006280N13
Recruiting
Phase 3

Evaluation of the effectiveness of dexmedetomidine in sedation of COVID-19 critically ill patients hospitalized in the intensive care unit , A double blind clinical trial

Vice President of Research Guilan university of medical sciences0 sites60 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Vice President of Research Guilan university of medical sciences
Enrollment
60
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Vice President of Research Guilan university of medical sciences

Eligibility Criteria

Inclusion Criteria

  • Patients aged 18 to 75 years admitted to the Intensive Care unit
  • clinical diagnosis of respiratory distress and breathing distress
  • Oxygen saturation less than 93% or positive polymerase chain reaction test
  • connected to non\-invasive or invasive ventilation
  • requiring sedative administration.

Exclusion Criteria

  • Pregnant patients
  • Known allergies to opioid drugs or dexmedomeidine.

Outcomes

Primary Outcomes

Not specified

Similar Trials